SPECIAL ARTICLE
Nephroangiosclerosis: an update
Nefroangioesclerosis: actualización
M. Heras Benito
Servicio de Nefrología, Hospital Universitario de Salamanca, Salamanca, España
Share
ISSN: 1889-1837
Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores
-
Envío de manuscritos
Indexed in:
Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME
See moreFollow us:
Subscribe:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2022
0.6
Citescore 2022
1.3
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2022
0.163
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2022
0.26
View more metrics
Hide
Journal Information
Special content about COVID-19
- Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration
- Niveles plasmáticos de troponina T y de la fracción aminoterminal del propéptido natriurético cerebral y su relación con mortalidad en COVID-19
- Impacto de la pandemia COVID-19 en la atención al ictus
- Miocarditis y trombosis in situ en ventrículo derecho en paciente COVID-19
Publish in
Hipertensión y Riesgo Vascular
Free access articles
Hipertens Riesgo Vasc. 2023;40:75-84
Hipertens Riesgo Vasc. 2022;39:174-94
Hipertens Riesgo Vasc. 2022;39:69-78